Arkzone-T 1.125

Description

Arkzone-T 1.125 is a powerful Cefoperazone + Tazobactam Injection, formulated to treat a wide range of serious bacterial infections. This combination includes Cefoperazone and Tazobactam, working together to deliver an effective broad-spectrum antibiotic injection for clinical use.

Key Benefits

• Provides strong action against resistant bacteria
• Enhances antibiotic effectiveness with beta-lactamase inhibition
• Suitable for severe and complicated infections
• Fast-acting antibacterial IV/IM therapy
• Reliable option for hospital settings

Arkzone-T works by disrupting bacterial cell wall formation while blocking enzymes that cause resistance. This dual mechanism ensures better outcomes in severe bacterial infection treatment, especially when standard antibiotics are less effective.

Common Uses

• Respiratory tract infections
• Urinary tract infections
• Intra-abdominal infections
• Skin and soft tissue infections
• Gynecological infections

Supplied as a sterile vial, Arkzone-T ensures accurate dosing and easy administration by healthcare professionals. The balanced composition of Cefoperazone 1000 mg and Tazobactam 125 mg makes it a preferred hospital antibiotic vial for critical care.

Why Choose Arkzone-T?

• Clinically proven combination therapy
• Broad-spectrum antibacterial coverage
• Helps overcome antibiotic resistance
• Trusted by healthcare professionals

Conclusion:

Arkzone-T 1.125 is a dependable Cefoperazone + Tazobactam Injection that delivers powerful, broad-spectrum protection, making it essential for modern infection management.